Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Peringkat dalam Saham #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Harga Saham
$0.11725176
Terakhir disinkronkan: 2025-07-14
Kapitalisasi Pasar
$481.50K
Perubahan (1 hari)
-0.20%
Perubahan (1 tahun)
0.00%
Negara
FR
Perdagangan PHAXIAM Therapeutics S.A. (PHXM)

Kategori

EPS untuk PHAXIAM Therapeutics S.A. (PHXM)
EPS per June 2024 TTM: $-4.23
Menurut laporan keuangan terbaru dan harga saham PHAXIAM Therapeutics S.A., EPS perusahaan saat ini (TTM) adalah $-4.23. Pada akhir 2022, perusahaan memiliki EPS sebesar $-0.07 penurunan dibandingkan dengan EPS tahun 2021 sebesar $-23.87.
Riwayat EPS untuk PHAXIAM Therapeutics S.A. dari 2016 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
2026 (TTM) $-4.23 -23.50%
2023 $-5.53 7,492.45%
2022 $-0.07 -99.69%
2021 $-23.87 -46.82%
2020 $-44.88 23.87%
2019 $-36.23 60.03%
2018 $-22.64 -30.76%
2017 $-32.70 21.96%
2016 $-26.81 0.00%
EPS untuk perusahaan sejenis atau pesaing
Perusahaan EPS Perbedaan EPS Negara
$17.32 -509.44%
US
$27.74 -755.76%
NL
- -
CH
- -
KR
$13.70 -423.86%
BE